Volume 27, Number 11—November 2021
Research
Hepatitis A Virus Incidence Rates and Biomarker Dynamics for Plasma Donors, United States
Figure 3

Figure 3. Geographic distribution of CDC-reported HAV outbreak cases, United States, as of February 2021, showing state-reported HAV outbreak cases as listed on the CDC website for the current outbreak since August 2016 (7). Outbreak-associated status is determined at state level in accordance with the respective outbreak case definition for each state. Therefore, HAV cases not classified as outbreak-associated are probably not captured in CDC data. CDC, Centers for Disease Control and Prevention; HAV, hepatitis A virus.
References
- Hollinger FB, Martin A. Hepatitis A virus. In: Knipe DM, Howley PM, editors. Fields virology, 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p.550–81.
- Martin A, Lemon SM, Hepatitis A. Hepatitis A virus: from discovery to vaccines. Hepatology. 2006;43(Suppl 1):S164–72. DOIPubMedGoogle Scholar
- Feng Z, Hensley L, McKnight KL, Hu F, Madden V, Ping L, et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature. 2013;496:367–71. DOIPubMedGoogle Scholar
- Asher LV, Binn LN, Mensing TL, Marchwicki RH, Vassell RA, Young GD. Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus). J Med Virol. 1995;47:260–8. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Viral hepatitis surveillance—United States, 2015 [cited 2020 Sep 5]. https://www.cdc.gov/hepatitis/statistics/SurveillanceRpts.htm
- Centers for Disease Control and Prevention. Viral hepatitis Surveillance—United States, 2018 [cited 2020 Sep 5]. https://www.cdc.gov/hepatitis/statistics/SurveillanceRpts.htm
- Yin S, Barker L, Ly KN, Kilmer G, Foster MA, Drobeniuc J, et al. Susceptibility to hepatitis A virus infection in the United States, 2007–2016. Clin Infect Dis. 2020;71:e571–9. DOIPubMedGoogle Scholar
- World Health Organization. The immunological basis for immunization series: module 18: hepatitis A. 2019, 1–68 [cited 2021 Aug 2]. https://apps.who.int/iris/bitstream/handle/10665/326501/97892516327-eng.pdf
- Foster M, Ramachandran S, Myatt K, Donovan D, Bohm S, Fiedler J, et al. Hepatitis A virus outbreaks associated with drug use and homelessness—California, Kentucky, Michigan, and Utah, 2017. MMWR Morb Mortal Wkly Rep. 2018;67:1208–10. DOIPubMedGoogle Scholar
- European Pharmacopeia. Human plasma for fractionation (monograph 853) [cited 2021 Aug 2]. https://pharmacopoeia.ru/en/fs-3-3-2-0001-15-plazma-cheloveka-dlya-fraktsionirovaniya
- Plasma Protein Therapeutics Association. International quality plasma program standards on donor health and donor management [cited 2021 Aug 2]. https://www.pptaglobal.org/safety-quality/standards/iqpp
- Gowland P, Fontana S, Niederhauser C, Taleghani BM. Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus. Transfusion. 2004;44:1555–61. DOIPubMedGoogle Scholar
- Marosevic D, Belting A, Schönberger K, Carl A, Wenzel JJ, Brey R. Hepatitis A outbreak in the general population due to a MSM-associated HAV genotype linked to a food handler, November 2017 – February 2018, Germany. Food Environ Virol. 2019;11:149–56. DOIPubMedGoogle Scholar
- Foster MA, Hofmeister MG, Kupronis BA, Lin Y, Xia GL, Yin S, et al. Increase in hepatitis A virus infections—United States, 2013–2018. MMWR Morb Mortal Wkly Rep. 2019;68:413–5. DOIPubMedGoogle Scholar
- Gallian P, Barlet V, Mouna L, Gross S, Lecam S, Ricard C, et al. Hepatitis A: an epidemiological survey in blood donors, France 2015 to 2017. Euro Surveill. 2018;23:
1800237 . DOIPubMedGoogle Scholar - Weimer T, Streichert S, Watson C, Gröner A. Hepatitis A virus prevalence in plasma donations. J Med Virol. 2002;67:469–71. DOIPubMedGoogle Scholar
- Bower WA, Nainan OV, Han X, Margolis HS. Duration of viremia in hepatitis A virus infection. J Infect Dis. 2000;182:12–7. DOIPubMedGoogle Scholar
- Johnston DE. Special considerations in interpreting liver function tests. Am Fam Physician. 1999;59:2223–30.PubMedGoogle Scholar
- Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis. 1995;171(Suppl 1):S15–8. DOIPubMedGoogle Scholar
- European Medicines Agency. Guideline on plasma-derived medicinal products (EMA/CHMP/BWP/706271/2010). Effective date: February 1, 2012 [cited 2021 Aug 2]. https://pdf4pro.com/view/guideline-on-plasma-derived-medicinal-products-2324eb.html
- Plasma Protein Therapeutics Association. QSEAL NAT Testing Standard (version 2.0). Effective date: June 13, 2013 [cited 2021 Aug 2]. https://www.pptaglobal.org/safety-quality/standards/qseal
- Friesema IH, Sonder GJ, Petrignani MW, Meiberg AE, van Rijckevorsel GG, Ruijs WL, et al. Spillover of a hepatitis A outbreak among men who have sex with men (MSM) to the general population, the Netherlands, 2017. Euro Surveill. 2018;23:
1800265 . DOIPubMedGoogle Scholar - Cohen JI, Ticehurst JR, Feinstone SM, Rosenblum B, Purcell RH. Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol. 1987;61:3035–9. DOIPubMedGoogle Scholar
- Costafreda MI, Abbasi A, Lu H, Kaplan G. Exosome mimicry by a HAVCR1-NPC1 pathway of endosomal fusion mediates hepatitis A virus infection. Nat Microbiol. 2020;5:1096–106. DOIPubMedGoogle Scholar
- Ott JJ, Wiersma ST. Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. Int J Infect Dis. 2013;17:e939–44. DOIPubMedGoogle Scholar
- Garner-Spitzer E, Kundi M, Rendi-Wagner P, Winkler B, Wiedermann G, Holzmann H, et al. Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees. Vaccine. 2009;27:197–204. DOIPubMedGoogle Scholar
- Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K. Hepatitis B NAT virus-positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang. 2005;88:77–86. DOIPubMedGoogle Scholar
- Ribeiro RM, Qin L, Chavez LL, Li D, Self SG, Perelson AS. Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J Virol. 2010;84:6096–102. DOIPubMedGoogle Scholar
- Busch MP, Giachetti C, Gallarda J, Mimms LT, Peddada L, Charles H, et al. Dynamics of HCV viremia during early HCV infection: Implications for minipool vs. individual donation nucleic acid amplification testing. Transfusion. 2000;40:S25.
- Weusten JJ, van Drimmelen HA, Lelie PN. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion. 2002;42:537–48. DOIPubMedGoogle Scholar
- Qu L, Lemon SM. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses. Semin Liver Dis. 2010;30:319–32. DOIPubMedGoogle Scholar